Nanotherapeutics Inc. is an emerging specialty pharmaceutical company with expertise in the early-stage development of pharmaceuticals. The company employs several platform technologies to manipulate and enhance the properties of drugs. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.
Significant advances have been made in the area of nanometer-scale particle delivery and Nanotherapeutics has created three proprietary drug delivery technologies: NanoQUAD™, NanoDRY™, and NanoCOAT™. These specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements and fewer side effects.
Advanced Materials Used in Military Technology
Nanotherapeutics Announces Conclusion of Type C Meeting with the US FDA
Nanotherapeutics Breaks Ground on Advanced Development and Manufacturing Center in Alachua, Florida
Nanotherapeutics Secures Funds to Conduct Clinical Trial on NanoDOX Hydrogel
Nanotherapeutics Files Investigational New Drug Application for NanoDTPA Capsule
Nanotherapeutics Acquires in Bankruptcy Proceedings Two Late Stage Clinical Programs
Nanotherapeutics Awarded Multi-Million Contract from National Institute of Allergy and Infectious Diseases
Nano Drug Company Submits Investigational New Drug Application with FDA for NanoBUP
Prof. Hongxia Wang
We speak with Professor Hongxia Wang from QUT about a new project that hopes to utilize graphene and other low-cost carbon materials to produce commercially viable, ultra low-cost, flexible perovskite solar cells.
Moti Segev & Vlad Shalaev
In this interview, AzoNano speaks to Professor Moti Segev and Professor Vladimir Shalaev, who made surprising discoveries about photonic time crystals that challenge existing research and theories.
Siyu Chen, Ph.D.
In this interview, we discuss a new approach to surface-enhanced Raman spectroscopy that utilizes nano-pockets to capture target molecules, ensuring a highly sensitive way to detect chemical processes.
This product profile from Merck outlines information about ultrastable fluorescent silica nanobeads.
The ClearView scintillator camera that elevates your everyday transmission electron microscopy (TEM).
Achieve high-throughput co-localized imaging and in-situ nanoindentation with Bruker’s Hysitron PI 89 Auto SEM.